# OnCo record dm4 (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/dm4/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "dm4" ;
  schema:name "DM4"@en ;
  schema:alternateName "ravtansine"@en, "soravtansine payload"@en, "ravtansine, soravtansine"@en ;
  schema:description "DM4 is a maytansinoid payload released in a form that can cross membranes, giving mirvetuximab soravtansine a bystander effect that DM1 lacks."@en ;
  schema:url <https://onco.cc/terms/dm4/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Ravtansine> ;
  schema:citation <https://doi.org/10.1021/jm060319f> ;
  onco:related <https://onco.cc/terms/bystander-effect/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:drugs <https://onco.cc/drugs/mirvetuximab-soravtansine/> ;
  onco:terms <https://onco.cc/terms/payload/>, <https://onco.cc/terms/tubulin-inhibitor-payloads/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-widdison-j-med-chem/> .